Pfizer plays a pivotal role in the development and commercialization of oncology treatments. The company's oncology portfolio comprises a broad range of therapies, targeting multiple types of cancer. These treatments include targeted therapies, immunotherapies, and combination regimens designed to combat cancer more effectively.
